Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	108 Pages	IHR Insights Pvt Limited	January, 2024	IFR18413827

Best Price Guarantee
Price	from $4,500
Length	108 Pages
Publisher	IHR Insights Pvt Limited
Published Date	January, 2024
SKU	IFR18413827

Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030

For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders is critical in the surveillance of these infectious diseases, boosting market growth in this field.

Inadequate reimbursements are a key problem impeding industry expansion. Medical testing has suffered a 40% decrease in reimbursement over the previous 40 years, according to MedPAC (Medicare Payment Advisory Commission). This reduction, as well as extra economic concerns among healthcare organisations, are significant impediments to the use of innovative diagnostic procedures in clinical laboratories.

1. Executive Summary
2. Industry Outlook: 2.1. Industry Overview; 2.2. Industry Trends
3. Market Snapshot: 3.1. Market Definition; 3.2. Market Outlook; 3.2.1. Porter Five Forces; 3.3. Related Markets
4. Market characteristics: 4.1. Market Overview; 4.2. Market Segmentation; 4.3. Market Dynamics; 4.3.1. Drivers; 4.3.2. Restraints; 4.3.3. Opportunities; 4.4. DRO - Impact Analysis
5. Product: Market Size & Analysis: 5.1. Overview; 5.2. Assays & Reagents; 5.3. Instruments; 5.4. Software
6. Disease Type: Market Size & Analysis: 6.1. Overview; 6.2. Hepatitis; 6.3. Human Immunodeficiency Virus; 6.4. Influenza; 6.5. Others
7. Technology: Market Size & Analysis: 7.1. Overview; 7.2. Immunodiagnostics; 7.3. Clinical Microbiology; 7.4. Polymerase Chain Reaction; 7.5. Next Generation Sequencing; 7.6. Others
8. Geography: Market Size & Analysis: 8.1. Overview; 8.2. North America (U.S., Mexico, Canada); 8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe); 8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC); 8.5. Latin America (Brazil, Argentina); 8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape: 9.1. Competitor Comparison Analysis; 9.2. Market Developments; 9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships; 9.2.2. Product Launches and execution
10. Vendor Profiles: 10.1. AMGEN, INC.; 10.1.1. Overview; 10.1.2. Financial Overview; 10.1.3. Product Offerings; 10.1.4. Developments; 10.1.5. Business Strategy; 10.2. ASTRAZENECA, PLC; 10.2.1. Overview; 10.2.2. Financial Overview; 10.2.3. Product Offerings; 10.2.4. Developments; 10.2.5. Business Strategy; 10.3. BAYER AG; 10.3.1. Overview; 10.3.2. Financial Overview; 10.3.3. Product Offerings; 10.3.4. Developments; 10.3.5. Business Strategy; 10.4. BRISTOL-MYERS SQUIBB COMPANY; 10.4.1. Overview; 10.4.2. Financial Overview; 10.4.3. Product Offerings; 10.4.4. Developments; 10.4.5. Business Strategy; 10.5. ELI LILY AND COMPANY; 10.5.1. Overview; 10.5.2. Financial Overview; 10.5.3. Product Offerings; 10.5.4. Developments; 10.5.5. Business Strategy; 10.6. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.); 10.6.1. Overview; 10.6.2. Financial Overview; 10.6.3. Product Offerings; 10.6.4. Developments; 10.6.5. Business Strategy; 10.7. PFIZER, INC.; 10.7.1. Overview; 10.7.2. Financial Overview; 10.7.3. Product Offerings; 10.7.4. Developments; 10.7.5. Business Strategy; 10.8. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC); 10.8.1. Overview; 10.8.2. Financial Overview; 10.8.3. Product Offerings; 10.8.4. Developments; 10.8.5. Business Strategy; 10.9. MERCK KGAA; 10.9.1. Overview; 10.9.2. Financial Overview; 10.9.3. Product Offerings; 10.9.4. Developments; 10.9.5. Business Strategy; 10.10. NOVARTIS AG; 10.10.1. Overview; 10.10.2. Financial Overview; 10.10.3. Product Offerings; 10.10.4. Developments; 10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure

PDF E-mail From Publisher:	$4,500
Site License Fulfilled by Publisher:	$5,000
Global Site License Fulfilled by Publisher:	$5,500

Show additional purchase options...

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase

Pharmacogenomics Market, by Technology (DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, and Other Technologies), by Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psyc

DNA Polymerase Market (Product Type: Taq Polymerase, Pfu Polymerase, and Others, and Application: Polymerase Chain Reaction, DNA Sequencing, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Global Forecast 2024-

Research Assistance

Other tasks